Cargando…

Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities

BACKGROUND: A new-generation low-energy linear accelerator (UNIQUE) was introduced in the clinical arena during 2009 by Varian Medical Systems. The world's first UNIQUE was installed at Oncology Institute of Southern Switzerland and put into clinical operation in June 2010. The aim of the prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Clivio, Alessandro, Nicolini, Giorgia, Vanetti, Eugenio, Fogliata, Antonella, Cozzi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197498/
https://www.ncbi.nlm.nih.gov/pubmed/21961830
http://dx.doi.org/10.1186/1748-717X-6-129
_version_ 1782214313440706560
author Clivio, Alessandro
Nicolini, Giorgia
Vanetti, Eugenio
Fogliata, Antonella
Cozzi, Luca
author_facet Clivio, Alessandro
Nicolini, Giorgia
Vanetti, Eugenio
Fogliata, Antonella
Cozzi, Luca
author_sort Clivio, Alessandro
collection PubMed
description BACKGROUND: A new-generation low-energy linear accelerator (UNIQUE) was introduced in the clinical arena during 2009 by Varian Medical Systems. The world's first UNIQUE was installed at Oncology Institute of Southern Switzerland and put into clinical operation in June 2010. The aim of the present contribution was to report experience about its commissioning and first year results from clinical operation. METHODS: Commissioning data, beam characteristics and the modeling into the treatment planning system were summarized. Imaging system of UNIQUE included a 2D-2D matching capability and tests were performed to identify system repositioning capability. Finally, since the system is capable of delivering volumetric modulated arc therapy with RapidArc, a summary of the tests performed for such modality to assess its performance in preclinical settings and during clinical usage was included. RESULTS: Isocenter virtual diameter was measured as less than 0.2 mm. Observed accuracy of isocenter determination and repositioning for 2D-2D matching procedures in image guidance was <1.2 mm. Concerning reproducibility and stability over a period of 1 year, deviations from reference were found <0.3 ± 0.2% for linac output, <0.1% for homogeneity, similarly to symmetry. Rotational accuracy of the entire gantry-portal imager system showed a maximum deviation from nominal 0.0 of <1.2 mm. Pre treatment quality assurance of RapidArc plans resulted with a Gamma Agreement Index (fraction of points passing the gamma criteria) of 97.0 ± 1.6% on the first 182 arcs verified. CONCLUSIONS: The results of the commissioning tests and of the first period of clinical operation, resulted meeting specifications and having good margins respect to tolerances. UNIQUE was put into operation for all delivery techniques; in particular, as shown by the pre-treatment quality assurance results, it enabled accurate and safe delivery of RapidArc plans.
format Online
Article
Text
id pubmed-3197498
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31974982011-10-21 Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities Clivio, Alessandro Nicolini, Giorgia Vanetti, Eugenio Fogliata, Antonella Cozzi, Luca Radiat Oncol Research BACKGROUND: A new-generation low-energy linear accelerator (UNIQUE) was introduced in the clinical arena during 2009 by Varian Medical Systems. The world's first UNIQUE was installed at Oncology Institute of Southern Switzerland and put into clinical operation in June 2010. The aim of the present contribution was to report experience about its commissioning and first year results from clinical operation. METHODS: Commissioning data, beam characteristics and the modeling into the treatment planning system were summarized. Imaging system of UNIQUE included a 2D-2D matching capability and tests were performed to identify system repositioning capability. Finally, since the system is capable of delivering volumetric modulated arc therapy with RapidArc, a summary of the tests performed for such modality to assess its performance in preclinical settings and during clinical usage was included. RESULTS: Isocenter virtual diameter was measured as less than 0.2 mm. Observed accuracy of isocenter determination and repositioning for 2D-2D matching procedures in image guidance was <1.2 mm. Concerning reproducibility and stability over a period of 1 year, deviations from reference were found <0.3 ± 0.2% for linac output, <0.1% for homogeneity, similarly to symmetry. Rotational accuracy of the entire gantry-portal imager system showed a maximum deviation from nominal 0.0 of <1.2 mm. Pre treatment quality assurance of RapidArc plans resulted with a Gamma Agreement Index (fraction of points passing the gamma criteria) of 97.0 ± 1.6% on the first 182 arcs verified. CONCLUSIONS: The results of the commissioning tests and of the first period of clinical operation, resulted meeting specifications and having good margins respect to tolerances. UNIQUE was put into operation for all delivery techniques; in particular, as shown by the pre-treatment quality assurance results, it enabled accurate and safe delivery of RapidArc plans. BioMed Central 2011-09-30 /pmc/articles/PMC3197498/ /pubmed/21961830 http://dx.doi.org/10.1186/1748-717X-6-129 Text en Copyright ©2011 Clivio et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Clivio, Alessandro
Nicolini, Giorgia
Vanetti, Eugenio
Fogliata, Antonella
Cozzi, Luca
Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
title Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
title_full Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
title_fullStr Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
title_full_unstemmed Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
title_short Commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
title_sort commissioning and early experience with a new-generation low-energy linear accelerator with advanced delivery and imaging functionalities
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197498/
https://www.ncbi.nlm.nih.gov/pubmed/21961830
http://dx.doi.org/10.1186/1748-717X-6-129
work_keys_str_mv AT clivioalessandro commissioningandearlyexperiencewithanewgenerationlowenergylinearacceleratorwithadvanceddeliveryandimagingfunctionalities
AT nicolinigiorgia commissioningandearlyexperiencewithanewgenerationlowenergylinearacceleratorwithadvanceddeliveryandimagingfunctionalities
AT vanettieugenio commissioningandearlyexperiencewithanewgenerationlowenergylinearacceleratorwithadvanceddeliveryandimagingfunctionalities
AT fogliataantonella commissioningandearlyexperiencewithanewgenerationlowenergylinearacceleratorwithadvanceddeliveryandimagingfunctionalities
AT cozziluca commissioningandearlyexperiencewithanewgenerationlowenergylinearacceleratorwithadvanceddeliveryandimagingfunctionalities